Testing effectiveness (Phase 2)Active Not RecruitingNCT03565783
What this trial is testing
Cemiplimab in Treating Patients With Recurrent and Resectable Stage II-IV Head and Neck Cutaneous Squamous Cell Cancer Before Surgery
Who this might be right for
Recurrent Cutaneous Squamous Cell Carcinoma of the Head and NeckResectable Cutaneous Squamous Cell Carcinoma of the Head and NeckStage II Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8+2 more
M.D. Anderson Cancer Center 44